A few months after Summit Therapeutics shocked the oncology world with an early claim that its lung cancer drug ivonescimab ...

An influential member in Congress is slated to publicly disavow the closely watched Biosecure Act ahead of a planned House ...

GSK’s Nucala passed a late-phase test in chronic obstructive pulmonary disorder, setting the stage for a showdown against a ...

Milestone’s calcium channel blocker succeeded in a late-phase trial in China in people with an abnormal heart rhythm disorder ...

A federal judge in Maryland has rejected a request from drugmakers and industry group PhRMA to stop a Maryland law that would ...

Cam­bridge, MA-based start­up Vesi­gen Ther­a­peu­tics is lay­ing off staff and “eval­u­at­ing strate­gic op­tions,” CEO ...

Travere Therapeutics won full approval for Filspari, which treats a rare autoimmune disease that affects the kidneys.

Ron Philip has stepped down as CEO at Roche’s Spark to run the show at Orbital Therapeutics, an RNA biotech tied to Beam ...

When looking to the future of the drug industry, the allure of Boston is strong. This week, the Japanese drugmaker Astellas ...

California biotech startup OrsoBio is betting the future of obesity drugs lies in combination approaches. To get there, ...

The FDA has raised con­cerns about po­ten­tial “in­ap­pro­pri­ate use” of Iterum’s oral can­di­date for un­com­pli­cat­ed ...

Researchers reported Sunday that atrial fibrillation patients who received Bayer’s experimental anticoagulant were ...